Medication info
Twinon Tablets 40/5 mg

Twinon Tablets 40/5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletTelmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Korea Chorus Co., Ltd.
Appearance
For domestic use: white or whitish rectangular tablets For export: white and light gray double-layer oval tablets with both sides convex.
Packaging
30 tablets/box [(10 tablets/Alu-Alu * 3)], 30 tablets/bottle
Approval status
Active

MFDS item code 201706876 · Approved 2017.08.29 · Insurance code 647204430

Summary

Main use
Treatment of essential hypertension uncontrolled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time every day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual ingredients (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual ingredients as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience (limited to this medicine 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and gradually increase the dose. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution when administered.’) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Korea Chorus Co., Ltd.

Efficacy & effects

Treatment of essential hypertension uncontrolled by monotherapy

  • Essential hypertension
View approved original text

This medication can effectively control blood pressure in patients with essential hypertension who are not sufficiently controlled with amlodipine or telmisartan monotherapy. Essential hypertension is characterized by persistently high blood pressure which increases the risk of cardiovascular diseases, making appropriate medication treatment extremely important. This product combines the advantages of both medications to improve blood pressure control and helps in the prevention of cardiovascular complications, making it a suitable treatment option for patients with challenging blood pressure management.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time every day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual ingredients (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual ingredients as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience (limited to this medicine 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and gradually increase the dose. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution when administered.’) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can pose a serious risk to the fetus during pregnancy, especially in the second and third trimesters; therefore, it should not be used by women who are pregnant or might become pregnant. This drug is contraindicated in patients with certain diseases, such as liver disease, severe hypotension, heart failure, unstable conditions after acute myocardial infarction, and biliary obstructive disease. Particular caution is needed for patients with primary aldosteronism, heart valve disease, impaired liver function, gastrointestinal disease, renal artery hypertension, patients undergoing dialysis, and the elderly when using this drug. Common symptoms while taking this medication may include dizziness and peripheral edema, but occasionally fainting or severe side effects can occur; therefore, consult medical personnel if any abnormal symptoms appear. This medication should not be taken during pregnancy, and it should be stopped immediately if pregnancy is confirmed, switching to another safe treatment method. As this medication lowers blood pressure, patients with low fluid or salt levels may experience hypotension, so it is essential to check the condition carefully before use and observe cautiously. This drug may increase potassium levels in the blood; hence, patients at risk of hyperkalemia should regularly monitor potassium levels through blood tests. Patients with impaired renal function may experience worsening kidney function while taking this drug; thus, regular blood tests to monitor kidney status are recommended. Patients with heart disease may see an increased risk of angina or myocardial infarction; therefore, they should be attentive to any changes in symptoms after taking this medication. This drug can cause drowsiness or dizziness, so caution should be exercised when driving or operating dangerous machinery while taking it. There may be interactions with other medications, so especially when taken with digoxin, lithium, warfarin, certain anti-inflammatory analgesics, or grapefruit juice, it is important to consult medical personnel. Breastfeeding women are advised not to take this drug, and special caution is necessary when treating children or the elderly. In case of overdose, serious symptoms such as hypotension, changes in heart rate, or kidney failure may appear; therefore, immediate medical treatment should be sought.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusional state
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • decreased sensation
  • dysgeusia
  • tremors
  • extrapyramidal disorder
  • muscular hypertonia
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • shortness of breath
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • bowel obstruction due to gas
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • myasthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is preferable to store the drug at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and safety.

Appearance and packaging

Appearance

For domestic use: white or whitish rectangular tablets For export: white and light gray double-layer oval tablets with both sides convex.

Package unit

30 tablets/box [(10 tablets/Alu-Alu * 3)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.